Identification of Upregulators of Human ATP-Binding Cassette Transporter A1 via High-Throughput Screening of a Synthetic and Natural Compound Library

Abstract

The ATP-binding cassette transporter A1 (ABCA1) is a membrane transporter that directly contributes to high-density lipoprotein (HDL) biogenesis by mediating the cellular efflux of cholesterol and phospholipids to lipid-poor apolipoprotein A-I. Therefore, identification of a novel upregulator of ABCA1 would be beneficial for atherosclerosis prevention and/or therapy because of its pivotal role in cholesterol homeostasis and HDL metabolism. In this study, a high-throughput assay method for ABCA1 upregulators was developed and used for screening a synthetic and natural compound library. The cell-based high-throughput screen is conducted in a 96-well format using the human hepatoma HepG2 cells stably transfected with ABCA1 promoter-luciferase construct and calibrated with reference ABCA1 upregulators (oxysterols, 9-cis-retinoic acid, thiazolidinediones, cyclic adenosine monophosphate, verapamil, fenofibrate, and oncostatin M). Among 2600 compounds, 4 microbial compounds (pyrromycin, aclarubicin, daidzein, and pratensein) were picked up as hits by the high-throughput screening assay, and those compounds were further identified as upregulators of ABCA1 expression by real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis. (Journal of Biomolecular Screening 2008:648-656)

Keywords

ATP-binding cassette transporter A1 upregulator high-throughput screening atherosclerosis

References

Miller NE : Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589-597.

Gordon DJ , Rifkind BM : High-density lipoprotein: the clinical implications of recent studies . N Engl J Med 1989;321:1311-1316.

Castelli WP , Anderson K. , Wilson PW , Levy D. : Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol 1992;2:23-28.

Fielding CJ , Fielding PE: Molecular physiology of reverse cholesterol transport . J Lipid Res 1995;36:211-228.

Oram JF and Yokoyama S. : Apolipoprotein-mediated removal of cellular cholesterol and phospholipids . J Lipid Res 1996;37:2473-2491.

Glomset JA : The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-167.

Brooks-Wilson A. , Marcil M. , Clee SM , Zhang LH , Roomp K. , Dam MV , et al: Mutations in ABCA1 in Tangier disease and familial high density lipoprotein deficiency . Nat Genet 1999;22:336-345.

Bodzioch M. , Orso M. , Klucken J. , Langmann T. , Bottcher A. , Diederich W. , et al: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22:347-351.

Lawn RM , Wade DP , Garvin MR , Wang X. , Schwartz K. , Porter JG , et al: The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Res 1999;104:R25-R31.

10.

Heyden M. , Kastelein J. , Attie A. : Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 2001;42:1717-1726.

11.

Langmann T. , Klucken J. , Reil M. , Liebisch G. , Luciani MF , Chimini G. , et al: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999 ;257:29-33.

12.

Singaraja RR , Fievet C. , Castro G. , James ER , Hennuyer N. , Clee SM , et al: Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002 ;110:35-42.

13.

Joyce CW , Amar MJ , Lambert G. , Vaisman BL , Paigen B. , Najib-Fruchart J. , et al: The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 2002;99:407-412.

14.

Joseph SB , McKilligin E. , Pei L. , Watson MA , Collins AR , Laffitte BA , et al: Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002;99:7604-7609.

15.

Miao B. , Zondlo S. , Gibbs S. , Cromley D. , Hosagrahara VP , Kirchgessner TG , et al: Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 2004;45:1410-1417.

16.

Tontonoz P. , Mangelsdorf DJ : Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003;17:985-993.

17.

Costet P. , Luo Y. , Wang N. , Tall AR : Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000;275:28240-28245.

18.

Smith PK , Krohn RI , Hermanson GT , Mallia AK , Gartner FH , Provenzano MD , et al: Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.

19.

Zhang JH , Chung TDY , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.

20.

Schug J. , Overton GC : (1997) TESS: Transcription Element Search System on the World Wide Web (Univ. of Pennsylvania, Philadelphia), Technical Report CBIL-TR-1997-1001-v0.0.

21.

Repa JJ , Berge KE , Pomajzl C. , Richardson JA , Hobbs H. , Mangelsdorf DJ : Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002; 277:18793-18800.

22.

Tontonoz P. , Mangelsdorf DJ : Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003;17:985-993.

23.

Suzuki S. , Nishimaki-Mogami T. , Tamehiro N. , Inoue K. , Arakawa R. , Abe-Dohmae S. , et al: Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler Thromb Vasc Biol 2004 ;24:519-525.

24.

Arakawa R. , Tamehiro N. , Nishimaki-Mogami T. , Ueda K. , Yokoyama S. : Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent manner. Arterioscler Thromb Vasc Biol 2005 ;25:1095-1096.

25.

Oram JF , Heinecke JW : ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005;85:1343-1372.

26.

Minotti G. , Menna P. , Salvatorelli E. , Cairo G. , Gianni L. : Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185-229.

27.

Aiello RJ , Brees D. , Francone OL : ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 2003;23:972-980.

28.

Joyce C. , Freeman L. , Brewer HB Jr , Santamarina-Fojo S. : Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 2003; 23:965-971.

29.

Singaraja RR , Brunham LR , Visscher H. , Kastelein JJ , Hayden MR : Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003;23:1322-1332.

30.

Wang N. , Tall AR : Regulation and mechanisms of ATP-binding cassette transporter a1-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003;23:1178-1184.

31.

Brunham LR , Kruit JK , Iqbal J. , Fievet C. , Timmins JM , Pape TD , et al: Intestinal ABCA1 directly contributes to HDL biogenesis in vivo . J Clin Invest 2006;116:1052-1062.

32.

Wellington CL , Brunham LR , Zhou S. , Singaraja RR , Visscher H. , Gelfer A. , et al: Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J Lipid Res 2003;44:1470-1480.

33.

Basso F. , Freeman L. , Knapper CL , Remaley A. , Stonik J. , Neufeld EB , et al: Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003;44:296-302.

34.

Repa JJ , Turley SD , Lobaccaro JA , Medina J. , Li L. , Lustig K. , et al: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000;289:1524-1529.

35.

Chawla A. , Boisvert WA , Lee CH , Laffitte BA , Barak Y. , Joseph SB , et al: A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001;7:161-171.

36.

Chinetti G. , Lestavel S. , Bocher V. , Remaley AT , Neve B. , Torra IP , et al: PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001;7:53-58.

37.

Hall WL , Rimbach G. , Williams CM : Isoflavones and endothelial function. Nutr Res Rev 2005;18:130-144.

38.

Badeau R. : Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women. Menopause 2007;14:293-299.

39.

Yang Y. , Zhang ZB , Jiang W. , Gao L. , Zhao GY , Zheng ZH , et al: Identification of novel human high-density lipoprotein receptor up-regulators using a cell-based high-throughput screening assay. J Biomol Screen 2007;12:211-219.

40.

Rigotti A. , Miettinen HE , Krieger M. : The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003;24:357-387.

41.

Brockmann H. , Lenk W. : Actinomyceten-farbstoffe. VII. Pyrromycin. Chem Ber 1959;92:1904-1909.

42.

Larsen AK , Escargueil AE , Skladanowski A. : Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 2003;99:167-181.

43.

Campbell KJ , O'Shea JM , Perkins ND : Differential regulation of NF-κB activation and function by topoisomerase II inhibitors. Cancer 2006;6: 101-109.